Mark H. Drazner

Mark H. Drazner's AcademicInfluence.com Rankings

Mark H. Drazner

Medical

#2067

World Rank

#2464

Historical Rank

Cardiology

#177

World Rank

#182

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Mark H. Drazner Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mark H. Drazner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (9561)
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013) (5272)
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013) (3504)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. (2017) (2433)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. (2017) (1845)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. (2017) (1330)
B-type natriuretic peptide in cardiovascular disease (2003) (1085)
Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. (2010) (1035)
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness (2005) (966)
The Progression of Hypertensive Heart Disease (2011) (640)
Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine (2010) (596)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (467)
An Automated Model to Identify Heart Failure Patients at Risk for 30-Day Readmission or Death Using Electronic Medical Record Data (2010) (450)
Prevalence and Determinants of Troponin T Elevation in the General Population (2006) (425)
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome (2020) (422)
Impact of Body Mass and Body Composition on Circulating Levels of Natriuretic Peptides: Results From the Dallas Heart Study (2005) (401)
Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. (2001) (397)
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure (2021) (395)
Exercise Training in Patients With Heart Failure and Preserved Ejection Fraction: Meta-Analysis of Randomized Control Trials (2014) (356)
Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. (2004) (342)
Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. (2001) (309)
Left Ventricular Hypertrophy Is More Prevalent in Blacks Than Whites in the General Population: The Dallas Heart Study (2005) (303)
Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. (2021) (263)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (250)
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial. (2019) (236)
Value of Clinician Assessment of Hemodynamics in Advanced Heart Failure: The ESCAPE Trial (2008) (214)
Does load-induced ventricular hypertrophy progress to systolic heart failure? (2005) (206)
Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. (1999) (204)
A 4-Tiered Classification of Left Ventricular Hypertrophy Based on Left Ventricular Geometry: The Dallas Heart Study (2010) (191)
Cardiorespiratory Fitness and Classification of Risk of Cardiovascular Disease Mortality (2011) (190)
Corin Gene Minor Allele Defined by 2 Missense Mutations Is Common in Blacks and Associated With High Blood Pressure and Hypertension (2005) (188)
Left atrial structure and function and clinical outcomes in the general population. (2013) (184)
Women Have Higher Left Ventricular Ejection Fractions Than Men Independent of Differences in Left Ventricular Volume: The Dallas Heart Study (2006) (183)
2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee. (2019) (173)
Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors? (1989) (159)
Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. (2020) (152)
Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy. (2002) (143)
Relation of Regional Fat Distribution to Left Ventricular Structure and Function (2013) (140)
Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes. (1997) (133)
Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population. (2013) (127)
Corin I555(P568) Allele Is Associated With Enhanced Cardiac Hypertrophic Response to Increased Systemic Afterload (2007) (122)
Allocating scarce resources in real-time to reduce heart failure readmissions: a prospective, controlled study (2013) (114)
Association of Cystatin C With Left Ventricular Structure and Function: The Dallas Heart Study (2009) (114)
Characterization of a novel symptom of advanced heart failure: bendopnea. (2014) (111)
Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation. (2005) (107)
Correlation of impedance cardiography with invasive hemodynamic measurements in patients with advanced heart failure: the BioImpedance CardioGraphy (BIG) substudy of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) Trial. (2009) (107)
Potential contributing factors to noncompliance with dietary sodium restriction in patients with heart failure. (2002) (107)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (103)
Monoclonal antibodies reveal receptor specificity among G-protein-coupled receptor kinases. (1996) (101)
Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study. (2009) (99)
Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients. (2002) (96)
Sympathetic Neural and Hemodynamic Responses to Upright Tilt in Patients With Pulsatile and Nonpulsatile Left Ventricular Assist Devices (2013) (95)
The Role of the Clinical Examination in Patients With Heart Failure. (2018) (93)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (90)
Relationship of Right- to Left-Sided Ventricular Filling Pressures in Advanced Heart Failure: Insights From the ESCAPE Trial (2013) (89)
Left Ventricular Hypertrophy, Subclinical Atherosclerosis, and Inflammation (2007) (86)
Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction. (2004) (86)
Clinical outcomes after cardiac transplantation in muscular dystrophy patients. (2007) (85)
Association of cardiorespiratory fitness with left ventricular remodeling and diastolic function: the Cooper Center Longitudinal Study. (2014) (83)
Outcomes after emergency department discharge with a primary diagnosis of heart failure. (2001) (82)
Changes in mid-life fitness predicts heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: the Cooper Center Longitudinal Study. (2015) (80)
Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study). (2005) (78)
In-Depth Evaluation of a Case of Presumed Myocarditis After the Second Dose of COVID-19 mRNA Vaccine (2021) (77)
Plasma Osteoprotegerin Levels in the General Population: Relation to Indices of Left Ventricular Structure and Function (2007) (73)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. (2022) (71)
Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial. (2004) (67)
The transition from hypertrophy to failure: how certain are we? (2005) (67)
ACC 2015 Core Cardiovascular Training Statement (COCATS 4) (Revision of COCATS 3) (2015) (66)
Fulminant myocarditis (2008) (66)
Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based Cohorts (2017) (66)
Restoration of Pulsatile Flow Reduces Sympathetic Nerve Activity Among Individuals With Continuous-Flow Left Ventricular Assist Devices (2015) (64)
Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study). (2015) (63)
Third heart sound and elevated jugular venous pressure as markers of the subsequent development of heart failure in patients with asymptomatic left ventricular dysfunction. (2003) (62)
Mismatch of right- and left-sided filling pressures in chronic heart failure. (2011) (61)
Relation of lack of knowledge about dietary sodium to hospital readmission in patients with heart failure. (2008) (58)
Association between renal function and circulating levels of natriuretic peptides (from the Dallas Heart Study). (2008) (56)
Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta‐Analysis and Systematic Review (2015) (53)
Influence of Race on Death and Ischemic Complications in Patients With Non–ST-Elevation Acute Coronary Syndromes Despite Modern, Protocol-Guided Treatment (2005) (52)
Effect of pulsatile and nonpulsatile flow on cerebral perfusion in patients with left ventricular assist devices. (2014) (51)
Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction. (2011) (49)
Characteristics and outcomes in African American patients with decompensated heart failure. (2008) (49)
Early outcome of initiating amiodarone for atrial fibrillation in advanced heart failure. (2000) (47)
Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population. (2015) (47)
High-Sensitivity Cardiac Troponin I Assay to Screen for Acute Rejection in Patients With Heart Transplant (2014) (46)
Contemporary Epidemiology of Heart Failure in Fee-For-Service Medicare Beneficiaries Across Healthcare Settings (2017) (45)
Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per‐protocol analysis of CARRESS‐HF (2018) (45)
Predictors of Death in Adults With Duchenne Muscular Dystrophy–Associated Cardiomyopathy (2017) (44)
Left ventricular hypertrophy, aortic wall thickness, and lifetime predicted risk of cardiovascular disease:the Dallas Heart Study. (2010) (44)
Progression from normal to reduced left ventricular ejection fraction in patients with concentric left ventricular hypertrophy after long-term follow-up. (2011) (43)
Cardiomyopathy in Type 2 Diabetes (2008) (42)
Relationship of right- and left-sided filling pressures in patients with advanced heart failure: a 14-year multi-institutional analysis. (2012) (41)
Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure). (2014) (39)
A disproportionate elevation in right ventricular filling pressure, in relation to left ventricular filling pressure, is associated with renal impairment and increased mortality in advanced decompensated heart failure. (2015) (39)
COCATS 4 Task Force 13: Training in Critical Care Cardiology. (2015) (39)
Factors Associated With Left Atrial Remodeling in the General Population (2017) (38)
Utility of the Cylex assay in cardiac transplant recipients. (2008) (38)
Effects of early steroid withdrawal after heart transplantation. (2006) (36)
The Relationship of Right- and Left-Sided Filling Pressures in Patients With Heart Failure and a Preserved Ejection Fraction (2010) (35)
The Striking Similarities of Multisystem Inflammatory Syndrome in Children and a Myocarditis-like Syndrome in Adults: Overlapping Manifestations of COVID-19. (2020) (35)
Low voltage on the electrocardiogram is a marker of disease severity and a risk factor for adverse outcomes in patients with heart failure due to systolic dysfunction. (2006) (35)
Role of Hospital Volumes in Identifying Low-Performing and High-Performing Aortic and Mitral Valve Surgical Centers in the United States (2017) (35)
Association of cardiac troponin I with disease severity and outcomes in patients with pulmonary hypertension. (2013) (35)
The natural history of new-onset heart failure with a severely depressed left ventricular ejection fraction: implications for timing of implantable cardioverter-defibrillator implantation. (2012) (35)
Randomized comparison of the effects of rosiglitazone vs. placebo on peak integrated cardiovascular performance, cardiac structure, and function. (2010) (34)
Guidance for Timely and Appropriate Referral of Patients With Advanced Heart Failure: A Scientific Statement From the American Heart Association (2021) (34)
Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT (2019) (33)
Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study (2019) (33)
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF) (2013) (33)
High incidence of cytomegalovirus disease in D+/R- heart transplant recipients shortly after completion of 3 months of valganciclovir prophylaxis. (2008) (33)
Utilization of cardiac computed tomography angiography for the diagnosis of left ventricular assist device thrombosis. (2012) (32)
Perturbations in serum chloride homeostasis in heart failure with preserved ejection fraction: insights from TOPCAT (2018) (32)
Letermovir successfully used for secondary prophylaxis in a heart transplant recipient with ganciclovir‐resistant cytomegalovirus syndrome (UL97 mutation) (2018) (31)
Alpha2cDel322-325 and beta1Arg389 adrenergic polymorphisms are not associated with reduced left ventricular ejection fraction or increased left ventricular volume. (2007) (30)
Newer biomarkers in heart failure. (2009) (30)
CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial. (2019) (29)
Bendopnea and risk of adverse clinical outcomes in ambulatory patients with systolic heart failure (2017) (29)
Electrocardiographic findings in peripartum cardiomyopathy (2019) (29)
The prognostic value of the physical examination in patients with chronic heart failure. (2003) (28)
Prognostic Significance of Biomarkers in Predicting Outcome in Patients With Coronary Artery Disease and Left Ventricular Dysfunction: Results of the Biomarker Substudy of the Surgical Treatment for Ischemic Heart Failure Trials (2013) (28)
In-hospital cardiopulmonary arrests in patients with left ventricular assist devices. (2014) (28)
Hypertonic saline: a novel therapy for advanced heart failure? (2003) (27)
2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive Summary (2022) (27)
Dynamic Relation of Changes in Weight and Indices of Fat Distribution With Cardiac Structure and Function: The Dallas Heart Study (2017) (26)
The relationship of right- and left-sided filling pressures in patients with heart failure and a preserved ejection fraction. (2010) (26)
Sirolimus use and incidence of venous thromboembolism in cardiac transplant recipients (2012) (26)
Left ventricular geometry: does shape matter? (2007) (26)
Health insurance and cardiac transplantation: a call for reform. (2005) (24)
Use of a highly sensitive assay for cardiac troponin T and N-terminal pro-brain natriuretic peptide to diagnose acute rejection in pediatric cardiac transplant recipients. (2012) (23)
2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Manage (2017) (23)
Utility of routine immunofluorescence staining for C4d in cardiac transplant recipients. (2009) (22)
Feasibility of Remote Video Assessment of Jugular Venous Pressure and Implications for Telehealth. (2020) (22)
Implantation of a left ventricular assist device to provide long‐term support for end‐stage Duchenne muscular dystrophy‐associated cardiomyopathy (2017) (21)
Risk scores versus natriuretic peptides for identifying prevalent stage B heart failure. (2011) (21)
Increased prevalence of concentric left ventricular hypertrophy in African-Americans: Will an epidemic of heart failure follow? (2006) (21)
Association of Concentric Left Ventricular Hypertrophy With Subsequent Change in Left Ventricular End-Diastolic Volume: The Dallas Heart Study (2017) (20)
Cardiac magnetic resonance imaging to assess the impact of maternal habitus on cardiac remodeling during pregnancy. (2016) (20)
Systolic time ratio by impedance cardiography to distinguish preserved vs impaired left ventricular systolic function in heart failure. (2008) (20)
The prognostic value of the relationship between right atrial and pulmonary capillary wedge pressure in diverse cardiovascular conditions (2018) (18)
The association between plasma caspase-3, atherosclerosis, and vascular function in the Dallas Heart Study (2008) (18)
Long‐Term Follow‐up of a Heart Transplant Recipient with Documented Seroconversion to HIV‐Positive Status 1 Year After Transplant (2008) (18)
Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure (2020) (18)
Factors influencing the rate of flow through continuous-flow left ventricular assist devices at rest and with exercise. (2014) (17)
Association Between Bendopnea and Key Parameters of Cardiopulmonary Exercise Testing in Patients With Advanced Heart Failure. (2016) (17)
The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: A randomised, placebo-controlled trial (2012) (17)
Health insurance as a requirement to undergo cardiac transplantation: a national survey of transplant program practices. (2013) (17)
The Blurred Line between Gaming and Patient Advocacy: Heart Transplant Listing Decisions in the Modern Era. (2019) (16)
Breastfeeding, Cellular Immune Activation, and Myocardial Recovery in Peripartum Cardiomyopathy (2019) (15)
Unexpected BNP levels in patients with advanced heart failure: a tale of caution and promise. (2005) (15)
High-sodium food choices by southern, urban African Americans with heart failure. (2006) (14)
Durable Mechanical Circulatory Support in Patients With Amyloid Cardiomyopathy (2020) (14)
Left ventricular hypertrophy is more common in black than white hypertensives: is this news? (2004) (14)
Concentric left ventricular hypertrophy as assessed by cardiac magnetic resonance imaging and risk of death in cardiac transplant recipients. (2010) (14)
Impact of Vice President Cheney on public interest in left ventricular assist devices and heart transplantation. (2014) (14)
Unique Patterns of Cardiovascular Involvement in Coronavirus Disease-2019 (2020) (14)
Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF). (2018) (14)
Pancreatic gout masquerading as pancreatic cancer in a heart transplant candidate. (2009) (13)
Association of African Ancestry With Electrocardiographic Voltage and Concentric Left Ventricular Hypertrophy: The Dallas Heart Study (2018) (13)
2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Manage (2017) (12)
Body Mass Index, Natriuretic Peptides, and Risk of Adverse Outcomes in Patients With Heart Failure and Preserved Ejection Fraction: Analysis From the TOPCAT Trial (2018) (12)
A New Left Ventricular Assist Device - Better, but Still Not Ideal. (2018) (12)
Beta-blocker therapy in patients with heart failure in the urban setting: moving beyond clinical trials. (2004) (12)
Relation of lower hematocrit to progression from asymptomatic left ventricular dysfunction to symptomatic heart failure (from the Studies of Left Ventricular Dysfunction Prevention trial). (2005) (12)
Refining the classification of left ventricular hypertrophy to provide new insights into the progression from hypertension to heart failure (2016) (12)
Maternal Obesity Affects Cardiac Remodeling and Recovery in Women with Peripartum Cardiomyopathy (2018) (12)
The Effects of Maternal Position and Habitus on Maternal Cardiovascular Parameters as Measured by Cardiac Magnetic Resonance (2015) (11)
Clinical assessment of heart failure: utility of symptoms, signs, and daily weights. (2009) (11)
Association of Health Aging and Body Composition (ABC) Heart Failure score with cardiac structural and functional abnormalities in young individuals. (2010) (11)
SGLT2 Inhibition in Heart Failure with a Preserved Ejection Fraction - A Win against a Formidable Foe. (2021) (11)
Tailored therapy using dobutamine and nitroglycerin in advanced heart failure. (1999) (11)
Therapy of heart failure in African Americans: lessons from an urban public hospital. (2004) (10)
Successful use of the TandemHeart percutaneous ventricular assist device as a bridge to recovery for acute cellular rejection in a cardiac transplant patient. (2011) (10)
Angiotensin Receptor-Neprilysin Inhibition (ARNI) Therapy and Reverse Remodeling in Heart Failure With Reduced Ejection Fraction. (2019) (10)
Is impedance cardiography-derived systolic time ratio a useful method to determine left ventricular systolic dysfunction in heart failure? (2004) (10)
IIIB or not IIIB: a previously unanswered question. (2012) (10)
Stiff Left Atrial Syndrome After Multiple Percutaneous Catheter Ablations: Role for Invasive Hemodynamic Exercise Testing. (2017) (9)
Racial response to angiotensin-converting enzyme therapy in systolic heart failure. (2004) (9)
Assessing prognosis in heart failure: is hepatocyte growth factor the next B-type natriuretic peptide? (2005) (9)
Induction regimen and survival in simultaneous heart-kidney transplant recipients. (2018) (9)
Physical examination in heart failure (2002) (9)
Management of Arrhythmias After Heart Transplant (2021) (9)
Potentiation of beta-adrenergic signaling by gene transfer. (1997) (8)
Transthyretin V142I Genetic Variant and Cardiac Remodeling, Injury, and Heart Failure Risk in Black Adults. (2021) (8)
Continuous-Flow Circulatory Support: The Achilles Heel of Current-Generation Left Ventricular Assist Devices? (2015) (7)
Tolerability of sirolimus: a decade of experience at a single cardiac transplant center (2013) (7)
Measuring nonpulsatile blood pressure: say goodbye to the Doppler? (2013) (7)
Abstract 12898: Myocardial Recovery at Six Months in Peripartum Cardiomyopathy: Results of the NHLBI Multicenter IPAC study (2013) (7)
Blacks and whites have a similar prevalence of reduced left ventricular ejection fraction in the general population: the Dallas Heart Study (DHS). (2008) (6)
Supranormal Left Ventricular Ejection Fraction, Stroke Volume, and Cardiovascular Risk: Findings From Population-Based Cohort Studies. (2022) (6)
Relief and Prevention of Congestion in Heart Failure Enhance Quality and Length of Life. (2019) (6)
The impact of race on response to RAAS inhibition (2005) (6)
Is the inferior vena cava really superior? (2013) (6)
Impact of induction immunosuppression on patient survival in heart transplant recipients treated with tacrolimus and mycophenolic acid in the current allocation era (2019) (6)
Variation of heart transplant rates in the United States during holidays (2014) (6)
Biomarkers of Cardiac Stress and Cytokine Release Syndrome in COVID-19: A Review (2021) (6)
Do established biomarkers such as B-type natriuretic peptide and troponin predict rejection? (2013) (6)
Combining Biomarkers and Imaging for Short‐Term Assessment of Cardiovascular Disease Risk in Apparently Healthy Adults (2020) (5)
Nesiritide in acute heart failure (2003) (5)
Implications of renin‐angiotensin‐system blocker discontinuation in acute decompensated heart failure with systolic dysfunction (2019) (5)
Left ventricular hypertrophy in special populations (2005) (5)
ACCF/AHA Practice Guideline (2013) (4)
Temporal association between hospitalization event and subsequent risk of mortality among patients with stable chronic heart failure with preserved ejection fraction: insights from the TOPCAT trial (2019) (4)
2020 ACC/HFSA/ISHLT Lifelong Learning Statement for Advanced Heart Failure and Transplant Cardiology Specialists: A Report of the ACC Competency Management Committee. (2020) (4)
Cross‐Sectional Associations of Objectively Measured Sedentary Time, Physical Activity, and Fitness With Cardiac Structure and Function: Findings From the Dallas Heart Study (2021) (4)
2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Manage (2017) (4)
Implementation of the 2022 AHA/ACC/HFSA Heart Failure Guideline: A Call to Action. (2022) (4)
Improved outcomes in patients awaiting heart transplantation: making the case that status 2 patients should not undergo transplantation (2002) (3)
Impact of bendopnea on postoperative outcomes in patients with severe aortic stenosis undergoing aortic valve replacement. (2018) (3)
The Effect of Pulsatile and Nonpulsatile Flow on Cerebral Perfusion in Patients with LVADs (2014) (3)
Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathy (2018) (3)
Right–Left Mismatch in the ESCAPE Population: Discordance between Right and Left Sided Filling Pressures before and after Therapy (2009) (3)
Identifying Discordance of Right- and Left-Ventricular Filling Pressures in Patients With Heart Failure by the Clinical Examination (2021) (3)
Association of 4-Tiered Classification of Left Ventricular Hypertrophy With Adverse Cardiovascular Outcomes in the General Population (2015) (3)
125: Treatment of HLA sensitized pre-transplant patients with mechanical support is effective for PRA reduction (2007) (3)
Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population. (2021) (3)
2020 ACC/HFSA/ISHLT Lifelong Learning Statement for Advanced Heart Failure and Transplant Cardiology Specialists: A Report of the ACC Competency Management Committee. (2020) (3)
Respiratory Syncytial Virus Pneumonia Treated with Lower-Dose Palivizumab in a Heart Transplant Recipient (2011) (3)
Heterozygous Cystic Fibrosis Transmembrane Regulator Gene Missense Variants Are Associated With Worse Cardiac Function in Patients With Duchenne Muscular Dystrophy (2020) (3)
Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study). (2021) (3)
Contemporary Reviews in Cardiovascular Medicine The Progression of Hypertensive Heart Disease (2011) (3)
Nesiritide in acute heart failure. Authors' reply (2003) (3)
Racial differences in heart failure. (2009) (3)
The Next Generation. (2022) (3)
Vaccines, Antibodies and Donors: Varying Attitudes and Policies Surrounding COVID-19 and Heart Transplantation (2022) (3)
Discordance Between Severity of Heart Failure as Determined by Patient Report Versus Cardiopulmonary Exercise Testing (2021) (2)
579 Blood Pressure Measurement in Patients with Continuous Flow LVADs: Comparing the Doppler Sphygmomanometer, the Nexfin Device, and the Arterial Line (2012) (2)
Comparison of Accuracy of Estimation of Cardiac Output by Thermodilution Versus the Fick Method Using Measured Oxygen Uptake. (2022) (2)
Abstract 2984: Non-pulsatile Left Ventricular Assist Device (LVAD) Patients Show Impaired Cerebral Autoregulation in Response to Upright Tilt (2009) (2)
#BeaconsOfLight (2021) (2)
Potentiation of (cid:98) -Adrenergic Signaling by Adenoviral-mediated Gene Transfer in Adult Rabbit Ventricular Myocytes (1997) (2)
Erratum: Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients (Journal of the American College of Cardiology (2002) 40 (311-317)) (2002) (2)
Abstract 17217: Serum Paraoxonase 1 (PON1) Activity is Associated With Indices of Hypertensive Heart Disease and Cardiac Remodeling in the Dallas Heart Study Population (2015) (2)
Delayed febrile response with bloodstream infections in patients with continuous-flow left ventricular assist devices (2019) (2)
260: Changes in the Causes of Heart Transplant Mortality over Two Decades: Successes, Failures and Opportunities (2010) (2)
Economic barriers in organ transplantation. (2008) (2)
Implications of Perceived Dyspnea and Global Well-Being Measured by Visual Assessment Scales During Treatment for Acute Decompensated Heart Failure. (2019) (2)
DISCONNECTION BETWEEN VOLUME LOSS AND INCREASING SERUM BICARBONATE DURING TREATMENT FOR ACUTELY DECOMPENSATED HEART FAILURE: A PER-PROTOCOL ANALYSIS OF CARRESS-HF (2018) (2)
EXERCISE CAPACITY AND MORTALITY IN PATIENTS WITH ISCHEMIC LEFT VENTRICULAR DYSFUNCTION RANDOMIZED TO CORONARY ARTERY BYPASS SURGERY OR MEDICAL THERAPY: AN ANALYSIS FROM THE SURGICAL TREATMENT FOR ISCHEMIC HEART FAILURE TRIAL (2014) (2)
Epidemiology and risk factors for varicella zoster virus reactivation in heart transplant recipients (2020) (2)
Phenomapping a Novel Classification System for Patients With Destination Therapy Left Ventricular Assist Devices. (2021) (2)
GLOBAL LONGITUDINAL STRAIN AT PRESENTATION IS PROGNOSTIC OF SUBSEQUENT LEFT VENTRICULAR RECOVERY IN PATIENTS WITH PERIPARTUM CARDIOMYOPATHY (2016) (2)
Intensive Blood Pressure Control and Body Size. (2018) (2)
Predicting Post-Heart Transplant Composite Renal Outcome Risk in Adults: A Machine Learning Decision Tool (2022) (2)
Hypoxemia in a patient with biventricular HeartWare® ventricular assist devices (2013) (1)
A risk score for predicting death in Chagas' heart disease. (2006) (1)
Erratum: Relationship of right- and left-sided filling pressures in patients with advanced heart failure: A 14-year multiinstitutional analysis (Journal of Heart and Lung Transplantation (2012) 31:1 (67-72)) (2012) (1)
Abstract 15784: Left Ventricular Structural Remodeling and Cardiomyopathy in Duchenne Muscular Dystrophy Carriers (2020) (1)
Insights From the History and Physical Examination in HFpEF or HFrEF: Similarities and Differences. (2021) (1)
Bidirectional Changes in Myocardial 18 F-Fluorodeoxyglucose Uptake After Human Ventricular Unloading (2022) (1)
Lung Ultrasound: Our New "Sixth Sense"? (2019) (1)
A Roadmap to Reinvigorating Training Pathways Focused on the Care of Patients with Heart Failure: Shifting from Failure to Function. (2022) (1)
RACIAL DIFFERENCES IN LEFT VENTRICULAR RECOVERY IN PATIENTS WITH PERIPARTUM CARDIOMYOPATHY ASSESSED BY GLOBAL LONGITUDINAL STRAIN (2017) (1)
Corrigendum (2011) (1)
161 Patients with INTERMACS 4-7 Heart Failure Have Reduced Quality of Life (2012) (1)
Reply: The Role of the Clinical Examination in Patients With Heart Failure. (2018) (1)
The Value of HFSA Membership. (2022) (1)
DIRECT COMPARISON OF ULTRAFILTRATION TO PHARMACOLOGICAL DECONGESTION IN HEART FAILURE: A PER-PROTOCOL ANALYSIS OF CARRESS-HF (2018) (1)
Response by de Lemos et al to Letter Regarding Article "Factors Associated With Left Atrial Remodeling in the General Population". (2017) (1)
Identification of high-sodium food choices by urban african-americans with heart failure (2004) (1)
Will the lessons from primary aldosteronism change the treatment of hypertension and left ventricular hypertrophy? (2007) (1)
The Importance of Celebration in Heart Failure. (2021) (1)
Subclinical myocardial injury and the phenotype of clinical congestion in patients with heart failure and reduced left ventrcular ejection fraction. (2021) (1)
Early efficacy and complications of initiating amiodarone for atrial fibrillation in advanced heart failure (1998) (1)
Association Between Center Level Characteristics And 1-Month Post-LVAD Implant Risk Standardized Mortality Rates (2022) (0)
5 6 Developed in Collaboration With the American Academy of Family Physicians, American College 7 of Chest Physicians, Heart Rhythm Society and International Society for Heart and Lung (2013) (0)
Health Insurance Is Usually Required for Heart Transplant Recipients but Not Donors; When Informed of this Discrepancy, Public Willingness to Donate May Decrease (2010) (0)
An Echo from the Past and a Look Towards the Future. (2022) (0)
Peripartum cardiomyopathy: balancing heart failure and motherhood (2003) (0)
328: Increased LV Mass and Concentricity as Assessed by Cardiac MRI Are Associated with Increased Mortality in Cardiac Transplant Recipients (2010) (0)
Abstract # 13498: Fitness and Reclassification of Risk For Cardiovascular Disease Mortality (2010) (0)
Clinical Importance of Markers of Congestion over Time in Patients with Heart Failure with Preserved Ejection Fraction (2019) (0)
Abstract 3193: The Progression From Concentric Left Ventricular Hypertrophy to Reduced Left Ventricular Ejection Fraction is Not Common After 7 Years (2009) (0)
STIFF LEFT ATRIAL SYNDROME FOLLOWING MULTIPLE ABLATIONS DIAGNOSED WITH INVASIVE HEMODYNAMIC EXERCISE TESTING (2017) (0)
Reply (2018) (0)
Abstract 16972: Midlife Cardiorespiratory Fitness Predicts Late-Life Risk for Heart Failure Independent of Interval Development of Hypertension, Diabetes, and Myocardial Infarction (2012) (0)
Evaluation of the acute heart failure patient: assessment of dyspnea and other physical examination parameters (2005) (0)
Association of Predicted Heart Mass from Mesa and Left Ventricular Mass from Dallas Heart Study with Heart Transplant Outcomes in the New Allocation System (2022) (0)
87: The Relationship of Right and Left Ventricular Filling Pressures in Patients Undergoing Cardiac Transplantation: A 17-Year Multi-Institutional Analysis (2009) (0)
39-P: Cross-reactive antibodies against donor HLA antigens do not correlate with graft outcome in heart allografts (2009) (0)
Abstract 980: Randomized Comparison of the Effects of Rosiglitazone versus Placebo on Peak Integrated Cardiovascular Performance, Cardiac Structure, and Function (2009) (0)
OXYGEN UPTAKE EFFICIENCY SLOPE IS ASSOCIATED WITH OUTCOME INDEPENDENTLY OF THE VE/VCO2 SLOPE: AN ANALYSIS OF HF-ACTION (2022) (0)
Omecamtiv Mecarbil as a Therapy for Heart Failure With Low Ejection Fraction. (2022) (0)
Does Induction Therapy for Heart Transplant Recipients on Tacrolimus/Mycophenolate/Prednisone Improve Survival in the Current Allocation Era? (2017) (0)
Blacks as Compared to Whites Do Not Have an Increased Prevalence of Reduced Left Ventricular Ejection Fraction in the General Population (2006) (0)
Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. (2023) (0)
African Americans have an increased prevalence of heart failure: the dallas heart study (2004) (0)
Failed Fontan Physiology with Associated Liver Disease in Adults- Are Two Organs Better Than One (2023) (0)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (0)
Restoration of Pulsatile Flow Leads to a Reduction in Sympathetic Nerve Activity Among Patients With Continuous-Flow Left Ventricular Assist Devices (2015) (0)
Sternal Sparing Left Ventricular Assist Devices in Patients with who Class 2 or Greater Obesity (2023) (0)
Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients with Diastolic Impairment and Preserved Ejection Fraction: A Meta-Analysis (2014) (0)
357: Does basiliximab decrease acute rejection and improve renal function in cardiac transplant recipients at mid-term follow-up (2006) (0)
Abstract 14833: Chronic Cardiac Injury Identifies a Malignant Left Ventricular Hypertrophy Phenotype in the General Population (2012) (0)
462: The effects of maternal position and habitus on left ventricular stroke volume during pregnancy measured by cardiac magnetic resonance (2015) (0)
54: Balancing Volume in Advanced Heart Failure before Heart Transplant: Mismatch between Right and Left Filling Pressures (2010) (0)
Donor name visibility in DonorNet. (2019) (0)
Bioelectrical impedance analysis: Can it help in the assessment of congestion? (2019) (0)
Association of Body Mass Index with Death, Mechanical Ventilation, and Cardiovascular Outcomes in COVID-19: Findings from the AHA COVID-19 Cardiovascular Disease Registry (2020) (0)
Hemodynamic Gain Index and Exercise Capacity in Heart Failure With Preserved Ejection Fraction. (2022) (0)
Racial Inequalities In The Allocation Of Left Ventricular Assist Devices: Insights From INTERMACS (2022) (0)
Abstract 24: Changes in Generalized and Central Adiposity are Dynamically Associated with Left Ventricular Remodeling (2016) (0)
Refining the Cold Profile in Patients With Acute Heart Failure. (2021) (0)
Hemodynamic and Cerebrovascular Response to an Orthostatic Challenge in Patients With Continuous-Flow Left Ventricular Assist Devices (2015) (0)
Influence of Device Type on Stroke Risk in Women Undergoing LVAD Implantation (2019) (0)
Left Ventricular Assist Devices in Advanced Heart Failure. (2022) (0)
Renal function is preserved following heart transplantation using IL-2 receptor blockade (2004) (0)
686 Early Detection and Resection of Lung Cancer in Heart Transplant Recipients Yields Similar Survival to Recipients without Lung Cancer (2012) (0)
(928) - Survival with Induction Therapy for Simultaneous Heart-Kidney Transplant Recipients on Tacrolimus/Mycophenolate (2017) (0)
Abstract 211: Apoptosis and Subclinical Atherosclerosis: Caspase-3 is Associated with Aortic Compliance and Coronary and Aortic Atherosclerosis in the Dallas Heart Study (2008) (0)
471: Utility of Basiliximab Induction at Mid-Term Follow-Up (2008) (0)
Abstract 14721: Association of Cardiorespiratory Fitness with Non-invasive Measures of Arterial and Ventricular Stiffness: The Dallas Heart Study (2014) (0)
ROLE OF HOSPITAL VOLUME IN IDENTIFYING LOW AND HIGH-PERFORMING SURGICAL VALVE CENTERS IN THE UNITED STATES (2017) (0)
PROGNOSTIC VALUE OF RIGHT-SIDED VOLUME OVERLOAD IN PATIENTS PRESENTING WITH ACUTE HEART FAILURE: INSIGHTS FROM ASCEND-HF (2016) (0)
Nonwhite race is associated with a higher rate of death and ischemic complications in patients with acute coronary syndromes despite modern early invasive treatment (2002) (0)
Phenomapping a Novel Classification System for Patients with Destination LVADs: An Unsupervised Machine Learning Cluster Analysis (2020) (0)
A Sensitive Cardiac Troponin I Assay to Screen for Acute Rejection in Heart Transplant Patients (2014) (0)
ASSOCIATION BETWEEN CARDIAC VARIABLES AND COGNITIVE FUNCTION IN MIDDLE-AGED ADULTS: ANALYSIS FROM THE DALLAS HEART STUDY-2 (2020) (0)
Abstract 12931: Myocardial Regeneration in End-stage Heart Failure After Left Ventricular Unloading (2020) (0)
INFLUENCE OF POST-IMPLANTATION NON-FATAL ADVERSE EVENTS ON CONDITIONAL SURVIVAL IN PATIENTS WITH DURABLE LEFT VENTRICULAR ASSIST DEVICE SUPPORT FOR DESTINATION THERAPY (2020) (0)
Reply: Bendopnea and pseudobendopnea. (2014) (0)
Bendopnea Is Due To Elevated Left Ventricular Filling Pressures Rather Than Elevated Pulmonary Artery Pressures (2023) (0)
Abstract 17809: The Cardiovascular Phenotype of D-Dimer: From the Dallas Heart Study (2011) (0)
The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction? (2022) (0)
INTENSIVE BLOOD PRESSURE CONTROL AND BODY SIZE: INSIGHTS FROM SPRINT (2018) (0)
A heartfelt story for the rich. (2006) (0)
Abstract 11725: Low Left Ventricular Mass and Cardiomyopathy in Muscular Dystrophies: A Different Perspective on Potential Cardiac Mechanisms (2021) (0)
THE ASSOCIATION OF THICK LEFT VENTRICULAR HYPERTROPHY WITH CARDIOVASCULAR OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: INSIGHTS FROM THE TOPCAT TRIAL (2017) (0)
OPTIMAL MEDICAL THERAPY USE AND LONG-TERM OUTCOMES IN CABG-ELIGIBLE HEART FAILURE PATIENTS: INSIGHTS FROM THE STICH TRIAL (2019) (0)
Fontan Failure with Arch Aneurysm and Cirrhosis Managed with Orthotopic Heart Transplantation and Arch Replacement Alone (2023) (0)
Abstract 15684: Discordance Between Severity of Heart Failure as Determined by Patient Report versus Cardiopulmonary Exercise Testing (2020) (0)
Clinical Characteristics and Outcomes in Patients with Mismatched Filling Pressures in Advanced Heart Failure: Looking beyond the JVP (2013) (0)
Abstract 15992: Nonpulsatile Flow Among Patients With Continuous-Flow Left Ventricular Assist Devices Leads to Greater Levels of Sympathetic Neural Activity Through Unloading of Arterial Baroreceptors (2014) (0)
089 - Implications of Renin-Angiotensin-System Blocker Discontinuation in Advanced Decompensated Heart Failure (2017) (0)
Erratum: Left ventricular hypertrophy, aortic wall thickness, and lifetime predicted risk of cardiovascular disease: The Dallas heart study (J Am Coll Cardiol Img (2010) 3 (605-613)) (2010) (0)
Do Something Amazing. (2022) (0)
Factors In fl uencing the Rate of Flow Through Continuous-Flow Left Ventricular Assist Devices at Rest and With Exercise * (2014) (0)
Dynamic Forecasts of Survival for Patients Living With Destination Left Ventricular Assist Devices: Insights From INTERMACS (2020) (0)
Should weight loss be targeted during an acute heart failure admission? (2022) (0)
LONGITUDINAL TRENDS IN LEFT VENTRICULAR MASS IN MUSCULAR DYSTROPHIES (2023) (0)
Abstract 14890: Diagnosing Duchenne Muscular Dystrophy-Associated Cardiomyopathy: Echocardiogram Shoots, Cardiac Magnetic Resonance Imaging Scores (2020) (0)
Noninvasive diagnostic evaluation of the acute heart failure patient with systolic dysfunction: focus on the electrocardiogram and chest x-ray (2005) (0)
Reply: "Bendopnea" or "kamptopnea?": Some thoughts on terminology and mechanisms. (2014) (0)
Comparing the Effect of Systolic Dysfunction on Outcomes By Sex In Patients with Heart Failure with Preserved Ejection Fraction (2020) (0)
Abstract 15821: Patients With Amyloid Cardiomyopathy Who Receive Durable Mechanical Circulatory Support Are at Increased Risk for Mortality and Early Adverse Events (2020) (0)
Three Takeaways from the HFSA Annual Scientific Meeting. (2021) (0)
Blood Pressure Control as a Risk Factor for Stroke in LVAD Patients- Single Center Experience (2018) (0)
Abstract 17733: Abnormalities in Left Atrial Structure and Function in the General Population (2010) (0)
A Novel Cytomegalovirus Prophylaxis Protocol in Cytomegalovirus (CMV) D+/R- Heart Transplant Recipients: A Single-Center Experience (2018) (0)
THE ASSOCIATION OF LEFT VENTRICULAR REMODELING WITH RIGHT VENTRICULAR STRUCTURE AND FUNCTION: THE MESA-RIGHT VENTRICLE STUDY (2011) (0)
The Role of Right Heart Catheterization in the Management of Patients with Heart Failure (2009) (0)
THE PROGNOSTIC VALUE OF LEFT ATRIAL FUNCTION BY SPECKLE TRACKING STRAIN IMAGING IN PATIENTS WITH PERIPARTUM CARDIOMYOPATHY (2018) (0)
THE PROGNOSTIC ROLE OF PRIOR HEART FAILURE HOSPITALIZATIONS IN PATIENTS WITH SEVERE SYMPTOMATIC AND RECURRENT HEART FAILURE: INSIGHTS FROM ESCAPE (2017) (0)
162-P: Presence of antibodies against MICA and MICB in heart allograft recipients is associated with development of coronary artery disease (2009) (0)
Economic Barriers in Organ Transplantation. Authors' reply (2008) (0)
Disentangling the Pulmonary Capillary Wedge Pressure From the Pulmonary Artery Pressure as the Hemodynamic Underpinning of Bendopnea. (2023) (0)
MYCOPHENOLATE MOFETIL DEMONSTRATES NO ADVANTAGE OVER AZATHIOPRINE ON STEROID WITHDRAWAL IN CARDIAC TRANSPLANT RECIPIENTS: A SINGLE CENTER EXPERIENCE (1999) (0)
Clinical Investigations In-Hospital Cardiopulmonary Arrests in Patients With Left Ventricular Assist Devices (2014) (0)
Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. (2023) (0)
CARDIAC FAILURE EDITOR-IN-CHIEF (2009) (0)
Initial BNP Level at Time of Referral Predicts Long-Term Mortality: A Retrospective Review of the UT Southwestern Heart Failure Database (2009) (0)
Abstract 10069: Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Left Ventricular Structure and Function in Duchenne Muscular Dystrophy Carriers (2021) (0)
THE HEMODYNAMIC GAIN INDEX AND CARDIORESPIRATORY FITNESS IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION - INSIGHTS FROM RELAX (2021) (0)
924-120 The Sick-Euthyroid Syndrome in Acute Myocardial Infarction (1995) (0)
THE ASSOCIATION OF RIGHT ATRIAL STRUCTURE AND FUNCTION WITH RIGHT VENTRICULAR EJECTION FRACTION AND INCIDENT DEATH OR TRANSPLANTATION IN CONGESTIVE HEART FAILURE PATIENTS (2014) (0)
Abstract 17965: Bendopnea is a Marker of Elevated VE/VC02 Slope in Patients With Heart Failure (2015) (0)
704: The impact of maternal habitus on cardiac remodeling during pregnancy and the puerperium (2015) (0)
Modern Management of Chronic Heart Failure: From Stage a to Stage D and beyond (2006) (0)
Patients with Continuous-Flow Left Ventricular Assist Devices Have a Reduced Baroreceptor Sensitivity Compared to Healthy Controls (2016) (0)
Device Choice Does Not Influence Outcomes after Left Ventricular Assist Device (LVAD) in Patients Bridged to Transplant or Destination Therapy (2017) (0)
SUITABILITY OF ICD-9 CODING AS THE BASIS FOR COMPARISONS OF HEART FAILURE PERFORMANCE: A PROSPECTIVE STUDY COMPARING CODING PROCEDURES TO CLINICIAN REVIEW (2011) (0)
Prognostic Value and Relationship Between Right Atrial and Pulmonary Capillary Wedge Pressure (2016) (0)
Abstract 14820: Association of the Orthodema Score and Invasively Measured Hemodynamics in Acute Decompensated Heart Failure (2018) (0)
COVID-19 and the Cardiovascular System (2020) (0)
Superior vena cava stenosis presenting with bendopnea (2021) (0)
Abstract 16619: Bendopnea, a Novel Symptom of Heart Failure, is Mediated via Elevated Left Ventricular Filling Pressures (2012) (0)
systolic heart failure? Does load-induced ventricular hypertrophy progress to (2016) (0)
ASSOCIATIONS OF ATRIAL VOLUME INDICES WITH HEMODYNAMIC PHENOTYPES IN HEART FAILURE (2023) (0)
455 U.S. Heart Transplant Rates Vary by Holiday (2012) (0)
Abstract 3657: Non-pulsatile Left Ventricular Assist Device (LVAD) Patients Have Exaggerated Hemodynamic and Autonomic Responses to Head up Tilting Compared to Pulsatile LVAD Patients and Controls (2009) (0)
Abstract 14874: Low Cardiorespiratory Fitness is Associated with Smaller Heart Size, Increased Concentricity and Worsening Diastolic Function: The Cooper Center Echocardiographic Sub-Cohort (2012) (0)
Abstract 14697: Left Ventricular Mass, Biomarkers of Myocardial Injury and Hemodynamic Stress, and Incident Heart Failure in Older Adults: The Cardiovascular Health Study (2013) (0)
Thermodilution Cardiac Index Has Poor Agreement with That Measured by the Direct Fick Method in Low-Output States (2021) (0)
COVID-19 and matters of the heart (2020) (0)
Book Review Diastology: Clinical Approach to Diastolic Heart Failure Edited by Allan L. Klein and Mario J. Garcia. 451 pp., illustrated, with CD-ROM. Philadelphia, Saunders, 2008. $169. 978-1-4160-3754-5 (2009) (0)
Abstract 023: Left Ventricular Hypertrophy and Elevated Biomarkers of Chronic Myocardial Injury May Identify African Americans With a Very High Risk for Heart Failure Development: Findings From The Jackson Heart Study (2018) (0)
Reproducibility of Acoustic Cardiography in Detecting a Third Heart Sound (2008) (0)
Treating Patients with Heart Failure and Mild Symptoms: Stay Awake at the Wheel. (2022) (0)
52: Desensitization Therapy Is Associated with Improved Survival to Transplant in Sensitized Patients Bridged with a Left Ventricular Assist Device (2009) (0)
Lack of Knowledge about Dietary Sodium Is a Risk Factor for Hospital Readmission in Patients with Heart Failure in an Urban Public Hospital (2006) (0)
Recognizing Efforts that Support Clinical Trial Success: Site-Based Research Awards from the Heart Failure Collaboratory and Heart Failure Society of America. (2022) (0)
Survival of the Unfittest: The Longest Living LVAD-Supported Patient with DMD-Associated Cardiomyopathy (2023) (0)
Abstract 13532: Diastolic Function at Presentation Has Independent Prognostic Value in Patients With Peripartum Cardiomyopathy (2015) (0)
Differential Impact of Ultrafiltration and Diuretics on Urine Sodium Excretion in Acute Heart Failure: Insights from CARRESS-HF (2018) (0)
The Clinical Examination in Patients with Heart Failure: New Insights (2022) (0)
Abstract 2385: Cystatin C is Associated with Left Ventricular Mass Independent of Traditional Markers of Renal Function in a Multiethnic Population-based Sample: The Dallas Heart Study (2007) (0)
Su1384: ASSOCIATION OF HEPATIC TRIGLYCERIDE CONTENT WITH CARDIAC STRUCTURE AND FUNCTION AMONG COMMUNITY-DWELLING ADULTS: FINDINGS FROM THE DALLAS HEART STUDY (2022) (0)
CHARACTERISTICS OF HIGH-PERFORMING HOSPITALS FOR CARDIOGENIC SHOCK FOLLOWING ACUTE MYOCARDIAL INFARCTION (2022) (0)
Contemporary Outcomes after Durable Left Ventricular Assist Device Explantation in Patients with Evidence of Cardiac Recovery (2021) (0)
Impact of body mass index on surgical coronary revascularization for ischaemic heart failure: insights from STICHES (2020) (0)
029 - Predictors of Global Well-Being and Dyspnea Changes during Treatment for Acute Decompensated Heart Failure (2017) (0)
IMPACT OF BODY SIZE ON SURGICAL CORONARY REVASCULARIZATION FOR ISCHEMIC HEART FAILURE: INSIGHTS FROM STICHES (2020) (0)
Voluntary Reporting of Guideline Directed Medical Therapy Utilization Rates in the Public Domain: A Challenge to the Heart Failure Community. (2023) (0)
35-P: Presence of donor specific antibodies against HLA-DQ in adult heart transplant recipients is associated with rejection (2009) (0)
(569) - Peak Exercise Oxygen Consumption in Patients Hospitalized with Severe and Recurrent Heart Failure: Insights from ESCAPE (2017) (0)
When can heart failure treatment be stopped safely? (2019) (0)
The Team is Larger Than I Thought. (2022) (0)
72: Donor Cardiopulmonary Resuscitation Does Not Impact Overall Survival and Cardiac Allograft Function in Heart Transplant Recipients (2010) (0)
Abstract 16962: Maladaptive Atrial Remodeling in Muscular Dystrophy (2020) (0)
COVID Silver Linings (2022) (0)
Subclinical Cardiac Injury And Clinical Congestion (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Mark H. Drazner?

Mark H. Drazner is affiliated with the following schools:

Duke University
University of Texas Southwestern Medical Center

Mark H. Drazner's Academic­Influence.com Rankings

Why Is Mark H. Drazner Influential?

Mark H. Drazner's Published Works

Published Works

What Schools Are Affiliated With Mark H. Drazner?

Mark H. Drazner's AcademicInfluence.com Rankings